Cvent (CVT) Drops 7.56% on February 08

Equities Staff  |

Cvent (CVT) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 7.56% to $20.91, a loss of $-1.71 per share. Starting at an opening price of $22.38 a share, the stock traded between $20.35 and $22.55 over the course of the trading day. Volume was 324,102 shares over 2,579 trades, against an average daily volume of 174,412 shares and a total float of 41.95 million.

The losses send Cvent down to a market cap of $877.21 million. In the last year, Cvent has traded between $37.25 and $22.58, and its 50-day SMA is currently $31.91 and 200-day SMA is $30.33.

Cvent Inc is engaged in providing a cloud-based enterprise event management platform. It provides solutions for both sides of the events and meetings value chain including the event & meeting planners and hotels & venues.

Cvent is based out of Tysons Corner, VA and has some 1,740 employees. Its CEO is Rajeev K. Aggarwal.

For a complete fundamental analysis analysis of Cvent, check out’s Stock Valuation Analysis report for CVT. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Crypto World in Review: Taking in the Good with the Bad

A lot happened in the cryptocurrency industry this week.

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…